Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
April 30, 1998
Study Completion Date
October 31, 2007
Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG
carboxyamidotriazole
DRUG
chemotherapy
Trial Locations (1)
20892-1182
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00019461 - Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter